Jaguar Health
JAGX • NASDAQ
Jaguar Health is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Lisa A. Conte, with a market cap of $2.5M.
CEOLisa A. Conte
Market Cap$2.5M
Biotechnology
Healthcare
Employees49.0
Websitejaguar.health
Country
United States of America
Next Earnings
Upcoming earnings announcement for Jaguar Health
Date
Monday, March 30, 2026 (in 2 months)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q4 2025
EPS Estimate
-$4.26
Revenue Estimate
$4.2M
Earnings History
Past 12 earnings reports for Jaguar Health
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 17, 2025 | Q3 2025 | -$6.28Est: -$4.26 | -47.4% | $3.1MEst: $4.2M | -26.8% |  10-Q |
| Aug 14, 2025 | Q2 2025 | -$10.25Est: -$7.13 | -43.8% | $3.0MEst: $3.3M | -8.9% | 10-Q |
| May 15, 2025 | Q1 2025 | -$16.70Est: -$10.82 | -54.3% | $2.2MEst: $2.8M | -21.5% | 10-Q |
| Mar 31, 2025 | Q4 2024 | -$8.44Est: -$18.50 | +54.4% | $3.5MEst: $3.1M | +12.1% | 10-K/A |
| Nov 13, 2024 | Q3 2024 | -$26.25Est: -$59.25 | +55.7% | $3.1MEst: $3.9M | -21.1% | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$101.00Est: -$27.75 | -264.0% | $2.7MEst: $3.9M | -30.9% | 10-Q |
| May 14, 2024 | Q1 2024 | -$1.50Est: -$0.75 | -100.0% | $2.4MEst: $3.0M | -20.6% | 10-Q |
| Apr 1, 2024 | Q4 2023 | $10.50 | — | $2.3MEst: $2.6M | -11.9% | 10-K/A |
| Nov 14, 2023 | Q3 2023 | -$9.50Est: -$30.75 | +69.1% | $2.8MEst: $2.5M | +14.3% | — |
| Aug 14, 2023 | Q2 2023 | -$10.50 | — | $2.7M | — | 10-Q |
| May 15, 2023 | Q1 2023 | -$59.75 | — | $2.0MEst: $3.9M | -49.4% | — |
| Mar 24, 2023 | Q4 2022 | $14.25Est: -$243.75 | +105.8% | $3.3MEst: $2.0M | +63.0% | — |